What is he best known for?
The fields of study he is best known for:
Genetics, Cancer research, Gene, Mutation and Carcinogenesis are his primary areas of study.
His Genetics study frequently links to other fields, such as Cell biology.
The concepts of his Cancer research study are interwoven with issues in Immunology, Point mutation, Tumor suppressor gene and Colorectal cancer, Adenomatous polyposis coli.
Gene and Molecular biology are frequently intertwined in his study.
His Mutation research includes elements of Phenotype, Malignancy and Cell growth.
His Carcinogenesis study combines topics from a wide range of disciplines, such as Tumor progression, KRAS and Carcinoma.
His most cited work include:
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity (21819 citations)
- A genetic model for colorectal tumorigenesis (9589 citations)
- WAF1, a potential mediator of p53 tumor suppression (7441 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Gene, Cancer research, Genetics, Molecular biology and Cancer.
Gene is frequently linked to DNA in his study.
While the research belongs to areas of Cancer research, Bert Vogelstein spends his time largely on the problem of Colorectal cancer, intersecting his research to questions surrounding Oncology.
His Genetics and Mutation, Allele, DNA mismatch repair, Genome and Chromosome investigations all form part of his Genetics research activities.
His study looks at the intersection of Molecular biology and topics like Cell biology with Cell cycle.
His study in Cancer focuses on Pancreatic cancer in particular.
He most often published in these fields:
- Gene (34.62%)
- Cancer research (34.51%)
- Genetics (32.80%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer (20.36%)
- Cancer research (34.51%)
- Internal medicine (12.54%)
In recent papers he was focusing on the following fields of study:
Bert Vogelstein spends much of his time researching Cancer, Cancer research, Internal medicine, Pathology and Oncology.
The various areas that he examines in his Cancer study include Aneuploidy, Computational biology and Stem cell.
The Cancer research study combines topics in areas such as Gene, Somatic cell, Blockade, Gene mutation and KRAS.
His Gene study is associated with Genetics.
His Pathology research integrates issues from Biomarker, Carcinogenesis and Bladder cancer.
His work in the fields of Oncology, such as Adjuvant, intersects with other areas such as In patient.
Between 2013 and 2021, his most popular works were:
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency (4640 citations)
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies (2454 citations)
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade (2396 citations)
In his most recent research, the most cited papers focused on:
Bert Vogelstein mostly deals with Cancer research, Cancer, Internal medicine, Mutation and Pathology.
His Cancer research study incorporates themes from Gene expression profiling, Carcinogenesis, Somatic cell, Gene mutation and Loss of heterozygosity.
His Cancer research is multidisciplinary, incorporating elements of Aneuploidy, Gold standard, Melanoma, Lung and Genetic heterogeneity.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
His Mutation study deals with the bigger picture of Genetics.
Bert Vogelstein interconnects Biomarker, KRAS, GNAS complex locus and Glioma in the investigation of issues within Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
